Colinz Laboratories Ltd
Colinz Laboratories Ltd (COLINZ) last traded at ₹71.1, a market capitalisation of ₹8.96 crore, on a P/E of 17.9. Over the past 52 weeks the stock has ranged between ₹36.1 and ₹87.9. Colinz Laboratories Ltd last reported results for the quarter ended Jun 2026, with sales of ₹1.24 crore and net profit of ₹2.4 crore. Colinz Laboratories Ltd’s annual general meeting is scheduled for 22 Sept 2026. Figures are as of 25 Aug 2026 and are not real time.
Colinz Laboratories Ltd share price and key metrics
Metrics as of 25 Aug 2026. Not real time.
Colinz Laboratories Ltd quarterly results
In the quarter ended Jun 2026, sales were ₹1.24 cr, down 21.0% from ₹1.57 cr a year earlier. Net profit was ₹2.4 cr, up 1900.0% year on year.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 1.86 | 1.47 | 1.45 | 1.57 | 1.39 | 1.43 | 1.75 | 1.24 |
| Expenses | 1.69 | 1.4 | 1.35 | 1.44 | 1.31 | 1.33 | 1.66 | 1.18 |
| Operating profit | 0.17 | 0.07 | 0.1 | 0.13 | 0.08 | 0.1 | 0.09 | 0.06 |
| OPM % | 9.14% | 4.76% | 6.90% | 8.28% | 5.76% | 6.99% | 5.14% | 4.84% |
| Other income | 0.08 | 0.08 | 0.08 | 0.08 | 0.16 | 0.08 | 0.17 | 2.89 |
| Interest | 0.01 | 0.01 | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Depreciation | 0.03 | 0.03 | 0.03 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 |
| Profit before tax | 0.21 | 0.11 | 0.13 | 0.16 | 0.19 | 0.13 | 0.21 | 2.9 |
| Tax % | 23.81% | 45.45% | -23.08% | 25.00% | 26.32% | 30.77% | 19.05% | 17.24% |
| Net profit | 0.16 | 0.05 | 0.15 | 0.12 | 0.14 | 0.08 | 0.17 | 2.4 |
| EPS (₹) | 0.64 | 0.20 | 0.60 | 0.48 | 0.56 | 0.32 | 0.67 | 9.53 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Colinz Laboratories Ltd annual results
| ₹ crore | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|
| Sales | 6.16 | 6.97 | 7.15 | 7.03 | 6.53 | 6.14 | 5.81 |
| Operating profit | 0.34 | 0.59 | 0.63 | 0.54 | 0.49 | 0.42 | 0.33 |
| OPM % | 5.52% | 8.46% | 8.81% | 7.68% | 7.50% | 6.84% | 5.68% |
| Net profit | 0.21 | 0.34 | 0.46 | 0.49 | 0.5 | 0.51 | 2.79 |
| EPS (₹) | 0.46 | 0.74 | 1.83 | 1.95 | 1.98 | 2.02 | 11.08 |
TTM is the trailing twelve months to the most recent quarter.
Colinz Laboratories Ltd growth and returns
- 10 Years
- -3%
- 5 Years
- 0%
- 3 Years
- -5%
- TTM
- -9%
- 10 Years
- 19%
- 5 Years
- 19%
- 3 Years
- 2%
- TTM
- 4%
- 10 Years
- 20%
- 5 Years
- 34%
- 3 Years
- 21%
- 1 Year
- 72%
- 10 Years
- 4%
- 5 Years
- 5%
- 3 Years
- 5%
- Last Year
- 5%
Colinz Laboratories Ltd shareholding pattern
Promoters held 50.60% at Jun 2026, down from 66.00% at Jun 2025.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 66.00% | 66.00% | 66.00% | 66.00% | 66.00% | 66.00% | 66.00% | 50.60% |
| Public | 34.00% | 33.99% | 33.99% | 34.00% | 33.99% | 34.00% | 34.00% | 49.39% |
| No. of shareholders | 3,116 | 3,202 | 3,216 | 3,238 | 3,272 | 3,212 | 3,250 | 3,174 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
When is Colinz Laboratories Ltd’s AGM?
Colinz Laboratories Ltd’s annual general meeting is scheduled for 22 Sept 2026.
- AGM40th AGM, adoption of financial statements, re-appointment of director, and appointment of Mrs. Vijaya Mani
See the full results calendar for every Indian company reporting in the next 30 days.
Colinz Laboratories Ltd corporate filings
- Dear Sir, Pursuant to Regulation 34(1) and Regulation 30 of SEBI(LODR),Regulations ,2015. Please find the attached our 40th Annual Report for the FY 2025-26. Kindly take the same on ....Otherslow impact
Cruxal's analysis: Colinz Laboratories Ltd has submitted its 40th Annual Report for the financial year…
Read the full analysis - Dear Sir, AS requied under Regulation 42 of SEBI(LODR) , Regulations, 2015 we are submitting herewith the Intimation towards closure of Book from 15-09-2026 to 22-09-2026 for the purpose ....Corp. Actionlow impact
Cruxal's analysis: Colinz Laboratories Ltd has notified the closure of its books from 15-09-2026 to…
Read the full analysis - As required under SEBI (LODR)Regulaions, 2015 and Section 108 Companies Act 2013 Reas with Rule 20 and other Applicable Rules thereunder, we are submitting herewith 40th AGM Notice of our ....AGM/EGMlow impact
Cruxal's analysis: Colinz Laboratories Limited has scheduled its 40th Annual General Meeting for 22nd…
Read the full analysis - Saffron Capital Advisors Pvt Ltd ("Manager to the Open Offer") has submitted to BSE a copy of Reminder Advertisement dated August 11, 2026 in relation to the open offer of Colinz Laboratories ....Company Updatehigh impact
Cruxal's analysis: Colinz Laboratories Limited is the subject of an open offer by the Dugar family (Annjana…
Read the full analysis - Saffron Capital Advisors Pvt Ltd ("Manager to the Open Offer") has submitted to BSE a copy of offer opening public announcement under Regulation 18(7) of the SEBI (SAST) Regulations, 2011, ....Company Updatehigh impact
Cruxal's analysis: Colinz Laboratories Limited is the subject of an open offer by Annjana Dugar, Likhitta…
Read the full analysis - Dear Sir, Submitting herewith the News Paper Clipping towards Advertiement in Newspaper towards submission of Declaration of Independent Directors Under SEBI SAST Regulation ,2011 and ....Company Updatelow impact
Cruxal's analysis: Colinz Laboratories Ltd has submitted a newspaper clipping dated August 5, 2026…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Track Colinz Laboratories Ltd
Cruxal reads every Colinz Laboratories Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.